Authors:
COUGHLIN CM
SALHANY KE
GEE MS
LATEMPLE DC
KOTENKO S
MA XJ
GRI G
WYSOCKA M
KIM JE
LIU L
LIAO F
FARBER JM
PESTKA S
TRINCHIERI G
LEE WMF
Citation: Cm. Coughlin et al., TUMOR-CELL RESPONSES TO IFN-GAMMA AFFECT TUMORIGENICITY AND RESPONSE TO IL-12 THERAPY AND ANTIANGIOGENESIS, Immunity (Cambridge, Mass.), 9(1), 1998, pp. 25-34
Authors:
BOXHORN HKE
SMITH JG
CHANG YJ
GUERRY D
LEE WMF
RODECK U
TURKA LA
ECK SL
Citation: Hke. Boxhorn et al., ADENOVIRAL TRANSDUCTION OF MELANOMA-CELLS WITH B7-1 - ANTITUMOR IMMUNITY AND IMMUNOSUPPRESSIVE FACTORS, Cancer immunology and immunotherapy, 46(5), 1998, pp. 283-292
Authors:
KOBLISH HK
HUNTER CA
WYSOCKA M
TRINCHIERI G
LEE WMF
Citation: Hk. Koblish et al., IMMUNE SUPPRESSION BY RECOMBINANT INTERLEUKIN (RIL)-12 INVOLVES INTERFERON-GAMMA INDUCTION OF NITRIC-OXIDE SYNTHASE-2 (INOS) ACTIVITY - INHIBITORS OF NO GENERATION REVEAL THE EXTENT OF RIL-12 VACCINE ADJUVANT EFFECT, The Journal of experimental medicine, 188(9), 1998, pp. 1603-1610
Authors:
COUGHLIN CM
SALHANY KE
WYSOCKA M
ARUGA E
KURZAWA H
CHANG AE
HUNTER CA
FOX JC
TRINCHIERI G
LEE WMF
Citation: Cm. Coughlin et al., INTERLEUKIN-12 AND INTERLEUKIN-18 SYNERGISTICALLY INDUCE MURINE TUMOR-REGRESSION WHICH INVOLVES INHIBITION OF ANGIOGENESIS, The Journal of clinical investigation, 101(6), 1998, pp. 1441-1452
Authors:
YEILDING NM
PROCOPIO WN
REHMAN MT
LEE WMF
Citation: Nm. Yeilding et al., C-MYC MESSENGER-RNA IS DOWN-REGULATED DURING MYOGENIC DIFFERENTIATIONBY ACCELERATED DECAY THAT DEPENDS ON TRANSLATION OF REGULATORY CODINGELEMENTS, The Journal of biological chemistry, 273(25), 1998, pp. 15749-15757
Authors:
KURZAWA H
WYSOCKA M
ARUGA E
CHANG AE
TRINCHIERI G
LEE WMF
Citation: H. Kurzawa et al., RECOMBINANT INTERLEUKIN-12 ENHANCES CELLULAR IMMUNE-RESPONSES TO VACCINATION ONLY AFTER A PERIOD OF SUPPRESSION, Cancer research, 58(3), 1998, pp. 491-499
Authors:
ARUGA E
ARUGA A
ARCA MJ
LEE WMF
YANG NS
SMITH JW
CHANG AE
Citation: E. Aruga et al., IMMUNE RESPONSIVENESS TO A MURINE MAMMARY-CARCINOMA MODIFIED TO EXPRESS B7-1, INTERLEUKIN-12, OR GM-CSF, Cancer gene therapy, 4(3), 1997, pp. 157-166
Citation: Nm. Yeilding et Wmf. Lee, CODING ELEMENTS IN EXON-2 AND EXON-3 TARGET C-MYC MESSENGER-RNA DOWN-REGULATION DURING MYOGENIC DIFFERENTIATION, Molecular and cellular biology, 17(5), 1997, pp. 2698-2707
Authors:
COUGHLIN CM
WYSOCKA M
TRINCHIERI G
LEE WMF
Citation: Cm. Coughlin et al., THE EFFECT OF INTERLEUKIN-12 DESENSITIZATION ON THE ANTITUMOR EFFICACY OF RECOMBINANT INTERLEUKIN-12, Cancer research, 57(12), 1997, pp. 2460-2467
Citation: Nm. Yeilding et al., IDENTIFICATION OF SEQUENCES IN C-MYC MESSENGER-RNA THAT REGULATE ITS STEADY-STATE LEVELS, Molecular and cellular biology, 16(7), 1996, pp. 3511-3522
Authors:
SAUTER MM
PELCHENMATTHEWS A
BRON R
MARSH M
LABRANCHE CC
VANCE PJ
ROMANO J
HAGGARTY BS
HART TK
LEE WMF
HOXIE JA
Citation: Mm. Sauter et al., AN INTERNALIZATION SIGNAL IN THE SIMIAN IMMUNODEFICIENCY VIRUS TRANSMEMBRANE PROTEIN CYTOPLASMIC DOMAIN MODULATES EXPRESSION OF ENVELOPE GLYCOPROTEINS ON THE CELL-SURFACE, The Journal of cell biology, 132(5), 1996, pp. 795-811
Citation: Lee Wmf",trinchieri, ROLE OF INTERLEUKIN-12 (IL12) AS AN ANTITUMOR AGENT - EXPERIMENTAL BIOLOGY AND CLINICAL-APPLICATION - COMMENTARY, Research in immunology, 146(7-8), 1995, pp. 636-638
Authors:
COUGHLIN CM
WYSOCKA M
KURZAWA HL
LEE WMF
TRINCHIERI G
ECK SL
Citation: Cm. Coughlin et al., B7-1 AND INTERLEUKIN-12 SYNERGISTICALLY INDUCE EFFECTIVE ANTITUMOR IMMUNITY, Cancer research, 55(21), 1995, pp. 4980-4987